CHARACTERIZATION OF THE TACHYKININ NK2 RECEPTOR IN THE HUMAN BRONCHUS - INFLUENCE OF AMASTATIN-SENSITIVE METABOLIC PATHWAYS

被引:12
作者
ASTOLFI, M
TREGGIARI, S
GIACHETTI, A
MEINI, S
MAGGI, CA
MANZINI, S
机构
[1] A MENARINI PHARMACEUT,FLORENCE,ITALY
[2] FORLANINI HOSP,DEPT THORAC SURG,ROME,ITALY
关键词
HUMAN BRONCHUS; AMASTATIN; NK2; RECEPTOR; TACHYKININS; AMINOPEPTIDASES; TACHYKININ ANTAGONISTS;
D O I
10.1111/j.1476-5381.1994.tb14775.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The aim of this study was to characterize the tachykinin NK2 receptor subtype mediating the spasmogenic response in the human isolated bronchus. The motor response to neurokinin A (NKA) and the selective NK2 agonist [beta Ala(8)]NKA(4-10), as well as the antagonistic effects of cyclic (L659,877) and linear (MEN 10376) peptide NK2 antagonists were assessed in the presence or absence of amastatin (an inhibitor of aminopeptidases A and M). 2 NKA was more potent than [beta Ala(8)]NKA(4-10) in eliciting bronchoconstriction (pD(2) being 7,43 and 6,87 respectively). In the presence of amastatin (1 mu M), the estimated affinity of [beta Ala(8)]NKA(4-10), but not that of NKA, was significantly increased to yield a pD(2) of 7,44. 3 L659,877 and MEN 10376 inhibited [beta Ala(8)]NKA(4-10)-induced contraction with similar affinities; pA(2) values were 5.7 +/- 0.22 and 6.3 +/- 0.32, respectively. Amastatin (1 mu M) increased the potency of MEN 10376 to 7.28 +/- 0.46, whereas that of L659,877 was unaffected. 4 In the presence of amastatin the pseudopeptide MDL 28,564 behaved as a partial agonist. 5 We conclude that the NK2 receptor subtype present in the human bronchus has properties similar to those described for the circular muscle of the human colon and thus may be classified as a 'NK2A' subtype. We show that the apparent potency of peptides, bearing N-terminal acidic residues, is influenced by an amastatin-sensitive peptidase, possibly aminopeptidase A.
引用
收藏
页码:570 / 574
页数:5
相关论文
共 27 条
  • [1] NEUROKININ A (NK2) RECEPTOR REVISITED WITH SR-48968, A POTENT NONPEPTIDE ANTAGONIST
    ADVENIER, C
    ROUISSI, N
    NGUYEN, QT
    EMONDSALT, X
    BRELIERE, JC
    NELIAT, G
    NALINE, E
    REGOLI, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (03) : 1418 - 1424
  • [2] RELATIVE POTENCIES OF NEUROKININS IN GUINEA-PIG TRACHEA AND HUMAN BRONCHUS
    ADVENIER, C
    NALINE, E
    DRAPEAU, G
    REGOLI, D
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 139 (02) : 133 - 137
  • [3] AHMAD S, 1990, J PHARMACOL EXP THER, V252, P643
  • [4] THE EFFECT OF AN INHALED NEUTRAL ENDOPEPTIDASE INHIBITOR, THIORPHAN, ON AIRWAY RESPONSES TO NEUROKININ-A IN NORMAL HUMANS INVIVO
    CHEUNG, D
    BEL, EH
    DENHARTIGH, J
    DIJKMAN, JH
    STERK, PJ
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (06): : 1275 - 1280
  • [5] COMPARISON OF THE EFFECTS OF EPITHELIUM REMOVAL AND OF AN ENKEPHALINASE INHIBITOR ON THE NEUROKININ-INDUCED CONTRACTIONS OF GUINEA-PIG ISOLATED TRACHEA
    DEVILLIER, P
    ADVENIER, C
    DRAPEAU, G
    MARSAC, J
    REGOLI, D
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (03) : 675 - 684
  • [6] RECEPTORS FOR NEUROKININS IN HUMAN BRONCHUS AND URINARY-BLADDER ARE OF THE NK-2-TYPE
    DION, S
    ROUISSI, N
    NANTEL, F
    DRAPEAU, G
    REGOLI, D
    NALINE, E
    ADVENIER, C
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 178 (02) : 215 - 219
  • [7] STRUCTURE-ACTIVITY STUDY OF NEUROKININS - ANTAGONISTS FOR THE NEUROKININ-2 RECEPTOR
    DION, S
    ROUISSI, N
    NANTEL, F
    JUKIC, D
    RHALEB, NE
    TOUSIGNANT, C
    TELEMAQUE, S
    DRAPEAU, G
    REGOLI, D
    NALINE, E
    ADVENIER, C
    ROVERO, P
    MAGGI, CA
    [J]. PHARMACOLOGY, 1990, 41 (04) : 184 - 194
  • [8] ELLIS J L, 1992, American Review of Respiratory Disease, V145, pA260
  • [9] GUILIANI S, 1991, EUR J PHARMACOL, V203, P365
  • [10] GUILIANI S, 1993, IN PRESS J PHARM EXP